Clinical Study of Toutongning Capsule Combined with Instant Cardio-reliever Pills and Metoprolol in the Treatment of Migraine
Abstract
Objective: To observe the clinical effect of Toutongning capsule combined with Instant Cardio-reliever pills, metoprolol in the treatment of migraine. Method: 150 cases of migraine were randomly divided into 3 groups, 50 cases in the treatment group. Using the headache Ning capsule combined with Instant Cardio-reliever pills, metoprolol treatment. The control group A50 cases, metoprolol combined with flunarizine hydrochloride treatment. The control group B50 cases, the application of the town of brain Ning capsule combined with quick acting to save the heart pill treatment, observation and comparison of 3 groups of migraine patients after treatment efficacy and symptom classification comparison. Results: After treatment in January, the effect of migraine in treatment group was significantly higher than that of the two control group (p < 0.05), and the symptom grade of treatment group was significantly improved compared with that of control group (p < 0.01). Conclusion: Headache Ning capsule combined with Instant Cardio-reliever pills, metoprolol in the treatment of migraine has significant curative effect, effective control of headache and to improve the quality of life in patients with migraine, and the safety is high, not prone to side effects, provides a new way to cure the ills of migraine.
References
2. Li MJ. Progress in the research on the pathogenesis of migraine. Chinese Clinical Neuroscience. 2007;10(3):314‒317.
3. Du YF. Discussing the role of pharmacotherapy in the treatment of migraine. Clinical Medicine Selection Handbook. Beijing: Jindun Publishing House;2008:110.
4. Zhu DS. Metoprolol and aspirin on migraine in 98 cases. Traffic medicine. 2008;22(4):405.
5. Su H. Research progress on the treatment and prevention of migraine. Journal of Guangdong Pharmaceutical University. 2008;04:360‒362.
Copyright (c) 2014 Hong Shao, Lingling Du, Jincui Sun, Chao Wang, Zhengjing Zhang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.